NASDAQ:SPRO - Spero Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$11.66 -0.04 (-0.34 %)
(As of 07/17/2018 04:00 PM ET)
Previous Close$12.12
Today's Range$11.66 - $12.12
52-Week Range$9.66 - $19.00
Volume6,488 shs
Average Volume120,859 shs
Market Capitalization$174.44 million
P/E Ratio-0.65
Dividend YieldN/A
BetaN/A

Analyst Ratings

Spero Therapeutics (NASDAQ:SPRO) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Spero Therapeutics in the last 12 months. Their average twelve-month price target is $27.75, suggesting that the stock has a possible upside of 137.99%. The high price target for SPRO is $30.00 and the low price target for SPRO is $26.00. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.832.832.802.75
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $27.75$27.75$27.6667$28.00
Price Target Upside: 137.99% upside135.17% upside83.83% upside133.53% upside

Spero Therapeutics (NASDAQ:SPRO) Consensus Price Target History

Price Target History for Spero Therapeutics (NASDAQ:SPRO)

Spero Therapeutics (NASDAQ:SPRO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/16/2018OppenheimerSet Price TargetBuy$30.00MediumView Rating Details
7/9/2018Cantor FitzgeraldSet Price TargetBuy$27.00HighView Rating Details
5/11/2018HC WainwrightInitiated CoverageBuy$28.00HighView Rating Details
11/27/2017Bank of AmericaInitiated CoverageNeutralHighView Rating Details
11/27/2017Stifel NicolausInitiated CoverageBuy ➝ Buy$26.00HighView Rating Details
11/27/2017CowenInitiated CoverageOutperformHighView Rating Details
(Data available from 7/17/2016 forward)
This page was last updated on 7/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.